학술논문
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study
Document Type
Article
Author
Sehgal, Alison ; Hoda, Daanish; Riedell, Peter A; Ghosh, Nilanjan; Hamadani, Mehdi; Hildebrandt, Gerhard C; Godwin, John E; Reagan, Patrick M; Wagner-Johnston, Nina; Essell, James; Nath, Rajneesh; Solomon, Scott R; Champion, Rebecca; Licitra, Edward; Fanning, Suzanne; Gupta, Neel; Dubowy, Ronald; D'Andrea, Aleco; Wang, Lei; Ogasawara, Ken; Thorpe, Jerill; Gordon, Leo I
Source
In The Lancet Oncology August 2022 23(8):1066-1077
Subject
Language
ISSN
1470-2045